Japan vs Landlocked developing countries (LLDCs): Proportion of the target population … measles-containing-vaccine
Japan
96.0%
in 2024
Landlocked developing countries (LLDCs)
65.0%
in 2024
Japan rank
28th
Landlocked developing countries (LLDCs) rank
27th
Proportion of the target population … measles-containing-vaccine over time
- Japan
- Landlocked developing countries (LLDCs)
How they compare
Japan currently reports 96.0% against 65.0% in Landlocked developing countries (LLDCs), a difference of 31.0%.
That makes Japan's figure about 1.5 times Landlocked developing countries (LLDCs)'s.
Across all 17 years both countries report, Japan has been ahead every year.
Japan ranks 28th and Landlocked developing countries (LLDCs) ranks 27th of 195 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.0% | 11.0% | 74.0% | Japan |
| 2010s | 93.5% | 26.7% | 66.8% | Japan |
| 2020s | 94.8% | 56.4% | 38.4% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Japan or Landlocked developing countries (LLDCs)?
- Japan, at 96.0% against 65.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received between Japan and Landlocked developing countries (LLDCs)?
- 31.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Landlocked developing countries (LLDCs)?
- 17 years are reported by both, from 2008 to 2024.
- How do Japan and Landlocked developing countries (LLDCs) rank globally for proportion of the target population who received?
- Japan ranks 28th and Landlocked developing countries (LLDCs) ranks 27th of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.